Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGAT1 | O75907 | 9/20 | 0.55 |
| ▸ | SOAT1 | P35610 | 2/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | DRD4 | P21917 | 3/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | F10 | P00742 | 1/20 | 0.48 |
| ▸ | DRD2 | P14416 | 2/20 | 0.47 |
| ▸ | SOAT2 | O75908 | 1/20 | 0.46 |
| ▸ | DGAT2 | Q96PD7 | 1/20 | 0.46 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15610649 | 0.95 | DGAT1 (0.51) | DGAT1SOAT1CYP3A4DRD4MEN1 | |
| SCHEMBL14127722 | 0.85 | DGAT1 (0.57) | DGAT1SOAT1CYP3A4DRD4KMT2A | |
| SCHEMBL670398 | 0.85 | DGAT1 (0.57) | DGAT1SOAT1CYP3A4DRD4KMT2A | |
| SCHEMBL16661049 | 0.84 | DGAT1 (0.56) | DGAT1SOAT1CYP3A4SOAT2DGAT2 | |
| SCHEMBL14127752 | 0.83 | DGAT1 (0.56) | DGAT1SOAT1CYP3A4DRD4KMT2A | |
| SCHEMBL16661302 | 0.82 | DGAT1 (0.56) | DGAT1SOAT1CYP3A4KMT2AF10 | |
| SCHEMBL15626638 | 0.82 | DGAT1 (0.56) | DGAT1SOAT1CYP3A4KMT2ASOAT2 | |
| SCHEMBL669645 | 0.82 | DGAT1 (0.54) | DGAT1SOAT1CYP3A4MEN1KMT2A | |
| Potassium Ion SCHEMBL15610648 | 0.82 | DGAT1 (0.54) | DGAT1SOAT1CYP3A4KMT2ASOAT2 | |
| SCHEMBL20190433 | 0.82 | NR1H4 (0.60) | POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140088124-A1 | IMIDAZOLE DERIVATIVES | INTERVET INC. | 2014-03-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140088124-A1 | IMIDAZOLE DERIVATIVES | DGAT1, DGAT2, SOAT1 | DGAT1 1/4885SOAT1 3/4885CYP3A4 2220/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.